Stay updated on PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now lists 74 study locations, including new entries in Port Charlotte, Florida, and two hospitals in Seoul, Korea, while the previous version had 72 locations and included West Palm Beach, Florida.
    Difference
    1%
    Check dated 2025-05-01T23:26:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-24T15:20:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of the Phase 1 and Phase 2 study protocols for the drug rezatapopt, while adding new information about various cancer types and registry identifiers related to the study.
    Difference
    16%
    Check dated 2025-04-17T07:08:48.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to reflect new details about the PC14586 study, including an increase in the number of study locations from 69 to 72, and the addition of specific recruiting sites in Delaware and New York. The last update date has also changed to April 2025.
    Difference
    2%
    Check dated 2025-04-09T23:40:30.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and last update date of March 4, 2025.
    Difference
    0.1%
    Check dated 2025-04-02T19:21:44.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the current status of the PC14586 study, including new enrollment details for the Phase 2 monotherapy and Phase 1b combination therapy portions, as well as the addition of new locations and contact information for study sites. The previous version's details about enrollment completion for certain phases have been removed.
    Difference
    10%
    Check dated 2025-03-11T00:39:26.000Z thumbnail image

Stay in the know with updates to PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.